How Experts Treat Large B-cell Lymphoma (LBCL)

Get up to date with the latest EHA Clinical Practice Guidelines for Large B-cell lymphoma (LBCL) (⁠Large B‐cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow‐up - Thieblemont - 2025 - HemaSphere - Wiley Online Library).⁠ 

Prof Catherine Thieblemont and Prof Marie José Kersten, two key authors of the guidelines,  walk us through the recommendations for Large B-cell lymphoma, covering diagnosis, treatment, and follow-up.

Gain insights into key diagnostic considerations including staging, biopsy techniques and the importance of molecular testing. Our guests explain treatment strategies for first-line and relapse/refractory patient populations, highlighting the practice-changing introduction of CAR T therapy in second-line for eligible patients. Finally, they discuss the disparities of access to innovative treatments across Europe and explore future perspectives of LBCL management in Europe and beyond. 

Guests: Prof Catherine Thieblemont and Prof Marie José Kersten.  

Professor Catherine Thieblemont from Saint-Louis Hospital in Paris. 

Professor Marie José Kersten from Amsterdam University Medical Centers (UMC) 

Learn More

What did you think of this podcast? Share your opinions with us in this short feedback survey.

⁠⁠⁠⁠⁠Provide Feedback⁠⁠⁠⁠⁠

Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.

⁠⁠⁠⁠⁠https://ehaedu.org/Campus⁠⁠⁠⁠⁠

Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.

Follow EHA on Instagram: ⁠⁠⁠⁠⁠https://www.instagram.com/EHA_Hematology/⁠⁠⁠⁠⁠

Facebook: ⁠⁠⁠⁠⁠https://e-h-a.link/facebook⁠⁠⁠⁠⁠

LinkedIn: ⁠⁠⁠⁠⁠https://www.linkedin.com/company/eha/⁠⁠⁠⁠⁠

Email us: [email protected]

Subscribe to receive the EHA Educational Updates via ⁠⁠⁠⁠⁠https://eha.news/subscribe⁠⁠⁠⁠⁠